Article
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
9 Apr 2024
Abstract excerpt
The transcription factor CCAAT/enhancer-binding protein-alpha( CEBPA ) is a critical mediator of granulocytic differentiation. Mutations of the CEBPA gene ( CEBPA mut ) occur in 5%–15% of adult AML patients and in-frame mutations within the bZIP domain of CEBPA ( CEBPA bZIP-inf ) define a distinct entity associated with favorable prognosis in AML patients when treated by conventional chemotherapy [ 1 , 2 ]. CEBPA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
